JADA-2001: Organon Jada Vacuum-Induced Postpartum Hemorrhage Control, Device Only (No Box)

Sign in to add this product to your favorites!
| Price: | $595.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 1 eaches |
| Expiration: | 09-2027 |
| Express: | Need it tomorrow? Order in next 4 hours 10 minutes and choose overnight shipping at checkout. |
Related Items
JADA-2002 $599.00 per kit Organon Jada Vacuum-Induced Postpartum Hemorrhage Control In-Date Out of Stock |
JADA-1001 $599.00 EACH Organon Jada Vacuum-Induced Hemorrhage Control (No Box) In-Date Out of Stock |
JADA-2001-SD $499.99 EACH Organon Jada Vacuum-Induced Postpartum Hemorrhage Control, Device Only (No Box) Exp: 10-2026 Units in stock: 1 | Order Qty |
G24237 - Size: 24.0F $445.00 EACH Cook Bakri Postpartum Balloon w/Rapid Instillation: 24F / 54cm, 500ml (No Box) Exp: 11-2026 Units in stock: 1 | Order Qty |
G24237-SD - Size: 24.0F $415.99 per box of 1 Cook Bakri Postpartum Balloon w/Rapid Instillation: 24F / 54cm, 500ml Exp: 08-2026 Units in stock: 1 box of 1 | Order Qty |
JADA-2002-SD $449.99 per kit Organon Jada Vacuum-Induced Postpartum Hemorrhage Control In-Date Out of Stock |
G24237 - Size: 24.0F $449.00 per box of 1 Cook Bakri Postpartum Balloon w/Rapid Instillation: 24F / 54cm, 500ml Exp: 12-2026 Units in stock: 10 box of 1 | Order Qty |
Additional Details
Organon Jada Vacuum-Induced Postpartum Hemorrhage Control
Item # JADA-2001
- Vacuum-Induced Hemorrhage Control System
- Does Not Include Accessories
AccessGUDID Info
- FDA Product Code: OQY
- FDA Product Code Name: Intrauterine Tamponade Balloon
- GMDN Term Code: 61558
- GMDN Term Name: Intrauterine haemostatic suction catheter
- GMDN Term Description: A sterile, flexible tube with a fenestrated loop at its distal end intended to be connected to a vacuum supply and inserted into the uterus to reduce postpartum bleeding through aspiration of blood/debris and induction of uterine contractions. It may have an additional balloon inflated in the upper vagina to seal the uterine cavity. This is a single-use device.
Manufacturer
Organon is a global healthcare company that focuses on women's health, biosimilars, and medicines for other unmet medical needs. It was spun off from Merck & Co. in 2021 and operates as an independent entity. Organon’s portfolio includes contraceptive products, fertility treatments, biosimilar medicines, and women's health therapies. The company is well known for offering products that address hormonal therapies, gynecological conditions, and family planning. Organon also has a growing focus on biosimilars in oncology and immunology. By focusing on improving health outcomes for women and addressing unmet medical needs, Organon strives to provide accessible, affordable healthcare solutions globally.
IN-DATE